Column Group LLC Q4 2024 Filing

Filed February 14, 2025

Portfolio Value

$55.7B

Holdings

5

Report Date

Q4 2024

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
ORICORIC Pharmaceuticals Inc.
3,540,777$28.6B51.26%
2
TNYATenaya Therapeutics, Inc.
9,400,290$13.4B24.12%
3
SRZNSurrozen, Inc.
810,088$11.6B20.85%
4
RAPTEURRAPT Therapeutics Inc
1,328,613$2.1B3.77%
5
RVMDRevolution Medicines Inc
46$2.1M0.00%